Identifying and Documenting Adverse Events at Clinical Study Sites

Improving adverse event reporting can lead to improved safety profiles and, consequently, fewer drugs pulled from the market.

Related Content:

View from BrusselsApplied Clinical Trials-05-01-2002

Cutting to the Chase on European "Safety Assessing Member States" in Clinical Trials

Helping Hands for Europe and Health?

European Drug Research Takes on A Wider Perspective